This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Callister, S. M. Articles by Lovrich, S. D. Search for Related Content PubMed PubMed Citation Articles by Callister, S. M. Articles by Lovrich, S. D.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 07 1996, 399-402, Vol 3, No. 4
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

SM Callister, DA Jobe, RF Schell, CS Pavia and SD Lovrich
Microbiology Research Laboratory, Gundersen Medical Foundation, La Crosse, WI 54601, USA.

The serodiagnosis of early Lyme disease has been plagued with problems of sensitivity and specificity. We found that the flow-cytometric borreliacidal-antibody test had a sensitivity of 72% for the detection of patients with early Lyme disease. By contrast, the sensitivity of the enzyme immunofluorescence assay was 28%. The enhanced sensitivity of the borreliacidal-antibody test was due to the use of Borrelia burgdorferi 50772, which lacks OspA and OspB. When B. burgdorferi 297, which expresses both OspA and OspB, was used, the sensitivity of the borreliacidal-antibody test was 15%. Our results also showed that the borreliacidal-antibody test was specific. No borreliacidal activity was detected in normal sera or in sera from patients with mononucleosis, rheumatoid factor, or syphilis. These results demonstrate that the flow- cytometric borreliacidal-antibody test may be the laboratory "gold standard" for the serodiagnosis of Lyme disease.

This article has been cited by other articles:

• Munson, E. L., Nardelli, D. T., Luk, K. H. K., Remington, M. C., Callister, S. M., Schell, R. F. (2006). Interleukin-6 Promotes Anti-OspA Borreliacidal Antibody Production In Vitro. CVI 13: 19-25 [Abstract] [Full Text]  
• Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I., Wormser, G. P. (2005). Diagnosis of Lyme Borreliosis. Clin. Microbiol. Rev. 18: 484-509 [Abstract] [Full Text]  
• Lovrich, S. D., Jobe, D. A., Schell, R. F., Callister, S. M. (2005). Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or Hamsters. CVI 12: 746-751 [Abstract] [Full Text]  
• Jobe, D. A., Lovrich, S. D., Schell, R. F., Callister, S. M. (2003). C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme Disease. CVI 10: 573-578 [Abstract] [Full Text]  
• Callister, S. M., Jobe, D. A., Agger, W. A., Schell, R. F., Kowalski, T. J., Lovrich, S. D., Marks, J. A. (2002). Ability of the Borreliacidal Antibody Test To Confirm Lyme Disease in Clinical Practice. CVI 9: 908-912 [Abstract] [Full Text]  
• Reed, K. D. (2002). Laboratory Testing for Lyme Disease: Possibilities and Practicalities. J. Clin. Microbiol. 40: 319-324 [Full Text]  
• Remington, M. C., Munson, E. L., Callister, S. M., Molitor, M. L., Christopherson, J. A., DeCoster, D. J., Lovrich, S. D., Schell, R. F. (2001). Interleukin-6 Enhances Production of Anti-OspC Immunoglobulin G2b Borreliacidal Antibody. Infect. Immun. 69: 4268-4275 [Abstract] [Full Text]  
• Callister, S. M., Jobe, D. A., Schell, R. F., Lovrich, S. D., Onheiber, K. L., Korshus, J. B. (2000). Detection of Borreliacidal Antibodies in Dogs after Challenge with Borrelia burgdorferi-Infected Ixodes scapularis Ticks. J. Clin. Microbiol. 38: 3670-3674 [Abstract] [Full Text]  
• KRAICZY, P., HUNFELD, K.-P., PETERS, S., WURZNER, R., ACKER, G., WILSKE, B., BRADE, V. (2000). Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant. J Med Microbiol 49: 917-928 [Abstract] [Full Text]  
• Exner, M. M., Wu, X., Blanco, D. R., Miller, J. N., Lovett, M. A. (2000). Protection Elicited by Native Outer Membrane Protein Oms66 (p66) against Host-Adapted Borrelia burgdorferi: Conformational Nature of Bactericidal Epitopes. Infect. Immun. 68: 2647-2654 [Abstract] [Full Text]  
• Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M. (2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev. 13: 167-195 [Abstract] [Full Text]  
• Wieneke, C. A., Lovrich, S. D., Callister, S. M., Jobe, D. A., Marks, J. A., Schell, R. F. (2000). Evaluation of Whole-Cell and OspC Enzyme-Linked Immunosorbent Assays for Discrimination of Early Lyme Borreliosis from OspA Vaccination. J. Clin. Microbiol. 38: 313-317 [Abstract] [Full Text]  
• Jobe, D. A., Rawal, N., Schell, R. F., Callister, S. M. (1999). Detection of Borreliacidal Antibodies in Lyme Borreliosis Patient Sera Containing Antimicrobial Agents. CVI 6: 930-933 [Abstract] [Full Text]